Search results for "From ACP Internist"


 
Results 41 - 50 of about 68 for "From ACP Internist".
Sort by: Relevance | Newest | Oldest

Task Force lowers age for colorectal cancer screening to begin

The U.S. Preventive Services Task Force recommended colorectal cancer screening begin at age 45 years based on an evidence review finding with moderate certainty that the net benefit is moderate to substantial.
https://gastroenterology.acponline.org/archives/2021/05/28/7.htm
28 May 2021

Low-value cancer screening may be commonly provided to older U.S. adults

An observational study found that patients often continued to be screened for cervical, breast, and colorectal cancer after passing guideline-recommended age thresholds.
https://gastroenterology.acponline.org/archives/2021/08/27/8.htm
27 Aug 2021

Be on alert for CRC in younger patients

A story in the September ACP Internist explained why medical groups are coming to consensus about expanded screening guidelines for colorectal cancer (CRC) that lower the age to begin screening.
https://gastroenterology.acponline.org/archives/2021/09/24/6.htm
24 Sep 2021

Flexible sigmoidoscopy associated with long-term reduction in colorectal cancer incidence, mortality

Colorectal cancer incidence and mortality were reduced by about 20% in patients who were randomized to receive once-only flexible sigmoidoscopy screening between the ages of 55 to 64 years instead of usual care.
https://gastroenterology.acponline.org/archives/2021/11/19/6.htm
19 Nov 2021

Phentermine-topiramate most effective drug for weight loss, meta-analysis finds

Among glucagon-like peptide-1 receptor agonists, semaglutide appeared to be the most effective for weight loss, with a higher likelihood of weight loss of 5% or more and percentage body weight change and a similar risk of adverse events.
https://gastroenterology.acponline.org/archives/2021/12/17/7.htm
17 Dec 2021

Apixaban shows superior effectiveness, safety compared to rivaroxaban

For patients with venous thromboembolism, initiation of apixaban was associated with lower rates of recurrence and intracranial and gastrointestinal bleeding than rivaroxaban in a population-based cohort study.
https://gastroenterology.acponline.org/archives/2021/12/17/6.htm
17 Dec 2021

AGA clinical practice update offers guidance on PPI deprescribing

All patients taking a proton-pump inhibitor (PPI) should have a regular review and documentation of ongoing indications for use, which should be the responsibility of the primary care clinician, the American Gastroenterological Association (AGA) said.
https://gastroenterology.acponline.org/archives/2022/02/25/6.htm
25 Feb 2022

Get comfortable talking about obesity

In this month's Pearls from I.M. Peers, a new video feature from ACP Internist, Kimberly N. Sims, MD, FACP, explained ways to make obesity counseling easier for patients and for their doctors.
https://gastroenterology.acponline.org/archives/2022/04/22/9.htm
22 Apr 2022

A new approach to diverticulitis

Evidence is fueling new guidelines suggesting internists treat most cases of uncomplicated diverticulitis in an outpatient setting, without antibiotics.
https://gastroenterology.acponline.org/archives/2022/04/22/8.htm
22 Apr 2022

Hepatitis B vaccine now recommended for adults ages 19 through 59 years

The Advisory Committee on Immunization Practices has changed its guidance to encourage clinicians to offer the vaccine to adult patients, rather than target those with risk factors or wait for it to be requested.
https://gastroenterology.acponline.org/archives/2022/04/22/6.htm
22 Apr 2022

Result Page: Prev   1   2   3   4   5   6   7   Next